1. Corporate Officers - H
2. Hanish Arnold C

Insider Trading History of Hanish Arnold C

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hanish Arnold C since 2019. This trader's CIK number is 1233253. At the time of last reporting, Hanish Arnold C was the Director of Salarius Pharmaceuticals, Inc.. (stock ticker symbol SLRX). Also see all insider trading activities at Salarius Pharmaceuticals, Inc..

Note that in the past HANISH ARNOLD C also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Salarius Pharmaceuticals, Inc. (SLRX) by Hanish Arnold C

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	SLRX	5,000	$3,740	0	$0	0	$0
2022	SLRX	28,000	$5,152	0	$0	0	$0
2021	SLRX	7,000	$6,167	0	$0	0	$0
2020	SLRX	8,350	$8,922	0	$0	0	$0
2019	SLRX	3,000	$10,770	0	$0	0	$0

Yearly summary of insider trading at Omeros Corp (OMER) by Hanish Arnold C

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	OMER	0	$0	5,000	$32,300	5,000	$26,500
2021	OMER	0	$0	0	$0	10,000	$94,400

Insider trading activities at 2 companies by Hanish Arnold C:

1. Salarius Pharmaceuticals, Inc. (SLRX)

2. Omeros Corp (OMER)

Table 1. Insider trading of Salarius Pharmaceuticals, Inc. (SLRX) by Hanish Arnold C

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-11-20	SLRX	Buy	5,000	.75	3,740
2022-06-03	SLRX	Buy	28,000	.18	5,152
2021-08-10	SLRX	Buy	7,000	.88	6,167
2020-08-21	SLRX	Buy	4,000	.98	3,920
2020-02-11	SLRX	Buy	4,350	1.15	5,002
2019-11-25	SLRX	Buy	3,000	3.59	10,770

Table 2. Insider trading of Omeros Corp (OMER) by Hanish Arnold C

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-05-22	OMER	Option Ex	5,000	5.30	26,500
2023-05-22	OMER	Sale	5,000	6.46	32,300
2021-09-08	OMER	Option Ex	10,000	9.44	94,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hanish Arnold C (Director of Salarius Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month